Encouraging Findings for Batten Disease Drug
The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH.
The FDA-approved, lipid-lowering medication gemfibrozil may prevent the progression of juvenile Batten disease, according to researchers at RUSH.
All three RUSH hospitals have again received the highest possible rating from the Leapfrog Group, a nonprofit health care watchdog organization that grades hospitals on the quality and safety of
Project allows students to ‘do something for someone else’
After a partial shoulder replacement, Tonia Logan can do things she hasn’t done in years
How to maintain a connection with a loved one.